Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for PCYC11$25  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$49  View Abstract
17-Apr-14New Constructs, LLCN/APCYC: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
12-Apr-14Alpha Street ResearchHunter OrrPCYC - Pharmacyclics Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24  View Abstract
12-Apr-14S&P Capital IQ Quantitative ReportN/APharmacyclics Inc11$126.50  View Abstract
11-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of PHARMACYCLICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
11-Apr-14Ford Investor Services, Inc.N/AValue Graph: PHARMACYCLICS -- PCYC1$11.50  View Abstract
11-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: AVEO , CPIX , KYTH , PCYC , POZN -- DRUGS3$34.50  View Abstract
28-Mar-14Wright ReportsN/AWright Investors Service Comprehensive Report for Pharmacyclics, Inc.41$75  View Abstract

Independent Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for PCYC11$25View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$49View Abstract
17-Apr-14New Constructs, LLCN/APCYC: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
12-Apr-14Alpha Street ResearchHunter OrrPCYC - Pharmacyclics Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24View Abstract
12-Apr-14S&P Capital IQ Quantitative ReportN/APharmacyclics Inc11$126.50View Abstract
11-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of PHARMACYCLICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
11-Apr-14Ford Investor Services, Inc.N/AValue Graph: PHARMACYCLICS -- PCYC1$11.50View Abstract
11-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: AVEO , CPIX , KYTH , PCYC , POZN -- DRUGS3$34.50View Abstract
28-Mar-14Wright ReportsN/AWright Investors Service Comprehensive Report for Pharmacyclics, Inc.41$75View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.